0.9031
price up icon1.47%   0.0131
after-market Handel nachbörslich: .89 -0.0131 -1.45%
loading
Schlusskurs vom Vortag:
$0.89
Offen:
$0.89
24-Stunden-Volumen:
39,018
Relative Volume:
0.18
Marktkapitalisierung:
$4.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-0.1885
EPS:
-4.79
Netto-Cashflow:
$-16.95M
1W Leistung:
-0.32%
1M Leistung:
+10.81%
6M Leistung:
+77.08%
1J Leistung:
+461.98%
1-Tages-Spanne:
Value
$0.8803
$0.94
1-Wochen-Bereich:
Value
$0.88
$1.04
52-Wochen-Spanne:
Value
$0.09
$4.49

Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile

Name
Firmenname
Matinas Biopharma Holdings Inc
Name
Telefon
908-443-1860
Name
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Name
Mitarbeiter
15
Name
Twitter
@MatinasBio
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
MTNB's Discussions on Twitter

Vergleichen Sie MTNB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MTNB
Matinas Biopharma Holdings Inc
0.9031 4.48M 0 -21.13M -16.95M -4.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-05-11 Herabstufung Piper Sandler Overweight → Neutral
2020-08-26 Fortgesetzt Piper Sandler Overweight
2020-01-27 Eingeleitet Piper Sandler Overweight
2020-01-24 Eingeleitet SunTrust Buy
2020-01-23 Eingeleitet SunTrust Buy
2020-01-09 Eingeleitet Aegis Capital Buy
2019-06-26 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten

pulisher
Jun 12, 2025

MTNB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jun 12, 2025
pulisher
Jun 06, 2025

Kalkine Matinas BioPharma Surges Amid NYSE Composite Market Momentum - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

Matinas Biopharma (NYSE:MTNB) Trading 5.7% Higher – Here’s Why - Defense World

Jun 06, 2025
pulisher
May 03, 2025

Matinas Biopharma (NYSE:MTNB) versus Marker Therapeutics (NASDAQ:MRKR) Head to Head Review - Defense World

May 03, 2025
pulisher
May 02, 2025

Matinas BioPharma amends bylaws, updates on officer agreements By Investing.com - Investing.com Canada

May 02, 2025
pulisher
May 02, 2025

Matinas BioPharma Amends Bylaws and Sets Annual Meeting - TipRanks

May 02, 2025
pulisher
May 02, 2025

Matinas BioPharma amends bylaws, updates on officer agreements - Investing.com

May 02, 2025
pulisher
Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 17, 2025

Matinas Biopharma (NYSE:MTNB) Shares Down 2.6% – Here’s What Happened - Defense World

Apr 17, 2025
pulisher
Apr 08, 2025

MTNB stock touches 52-week low at $0.48 amid sharp annual decline - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

MTNB stock touches 52-week low at $0.48 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 04, 2025

Matinas BioPharma secures shareholder nods on key proposals By Investing.com - Investing.com Australia

Apr 04, 2025
pulisher
Apr 04, 2025

Matinas BioPharma secures shareholder nods on key proposals - Investing.com

Apr 04, 2025
pulisher
Mar 31, 2025

Matinas Biopharma Delays 10-K Filing - TipRanks

Mar 31, 2025
pulisher
Mar 26, 2025

Matinas Biopharma (NYSE:MTNB) Shares Down 6.6% – Should You Sell? - Defense World

Mar 26, 2025
pulisher
Mar 17, 2025

Matinas BioPharma Chairman Eric Ende Resigns -March 17, 2025 at 05:08 am EDT - MarketScreener

Mar 17, 2025
pulisher
Mar 16, 2025

Matinas BioPharma announces board chairman’s departure By Investing.com - Investing.com Australia

Mar 16, 2025
pulisher
Mar 14, 2025

Matinas BioPharma announces board chairman’s departure - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma -March 14, 2025 at 05:48 pm EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 11, 2025

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Silicon Valley - Financial Content

Mar 11, 2025
pulisher
Mar 07, 2025

Matinas Biopharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Feb 14, 2025

12 Health Care Stocks Moving In Friday's Pre-Market SessionArtiva Biotherapeutics (NASDAQ:ARTV) - Benzinga

Feb 14, 2025
pulisher
Feb 13, 2025

Matinas Biopharma Announces Agreement For The Acquisition Of Preferred Stock And Appointment Of Dr. Robin L. Smith To The Board Of Directors - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

Matinas BioPharma Announces Agreement for the Acquisition - GlobeNewswire

Feb 13, 2025
pulisher
Feb 13, 2025

Biotech Deal Alert: Matinas BioPharma Lands Critical $3.3M Investment While Strengthening Leadership - StockTitan

Feb 13, 2025
pulisher
Feb 12, 2025

Matinas BioPharma announces board member retirement - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Matinas BioPharma announces board member retirement By Investing.com - Investing.com South Africa

Feb 11, 2025
pulisher
Feb 09, 2025

Matinas BioPharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire

Feb 09, 2025
pulisher
Feb 07, 2025

Matinas Biopharma Appoints Evelyn D’An as Director and Audit Committee Chair - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas BioPharma Appoints Evelyn D’An to Board - citybiz

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas BioPharma Holdings, Inc. Appoints Evelyn D?An to Board of Directors as an Independent Director and Chair of the Audit Committee - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas Biopharma Appoints Evelyn D'An To Board Of Directors As Audit Committee Chair - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - The Manila Times

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair - GlobeNewswire

Feb 07, 2025
pulisher
Jan 25, 2025

Matinas BioPharma announces board member resignation - MSN

Jan 25, 2025
pulisher
Jan 25, 2025

Matinas BioPharma announces board member resignation By Investing.com - Investing.com South Africa

Jan 25, 2025

Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Kapitalisierung:     |  Volumen (24h):